Literature DB >> 14943577

Progressive motor neuron disease in adults; a clinical study with special reference to the course of the disease.

R MULLER.   

Abstract

Entities:  

Keywords:  MOVEMENT DISORDERS

Mesh：

Year:  1952        PMID： 14943577     DOI： 10.1111/j.1600-0447.1952.tb04647.x

Source DB:  PubMed          Journal:  Acta Psychiatr Neurol Scand        ISSN： 0365-5598


× No keyword cloud information.
  8 in total

1.  Clinical features and associations of 560 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

2.  The central nervous system in motor neurone disease.

Authors:  B Brownell; D R Oppenheimer; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

3.  Sensory involvement in motor neuron disease: further evidence from automated thermal threshold determination.

Authors:  G A Jamal; A I Weir; S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

4.  A follow-up study of 60 cases of chronic spinal muscular atrophy.

Authors:  D Schiffer; F Brignolio; A Chiò; M T Giordana; P Meineri; M G Rosso; A Tribolo
Journal:  Ital J Neurol Sci       Date:  1988-02

5.  X-linked adult form of spinal muscular atrophy.

Authors:  I Hausmanowa-Petrusewicz; J Borkowska; Z Janczewski
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

6.  [Early forms of amyotrophic lateral sclerosis with special reference to the initial bulbar-paralytic syndrome].

Authors:  W Girke; J Kovarík
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1970

7.  X-linked recessive bulbospinal neuronopathy: a report of ten cases.

Authors:  A E Harding; P K Thomas; M Baraitser; P G Bradbury; J A Morgan-Hughes; J R Ponsford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-11       Impact factor: 10.154

8.  PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Authors:  Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.